News | ERT

50% OF ALL NDAs SUPPORTED SINCE 2014

June 2, 2020

FDA Patient-Focused Drug Development Guidance Update: Incorporating Patient Experience Data in Clinical Trials

Understand the four new methodological Patient-Focused Drug Development (PFDD) guidance documents that FDA has issued / currently has in development on incorporating patient experience data into drug development.

May 19, 2020

ERT Virtual Visit Capabilities Keep Clinical Trials on Track during COVID-19

Seamless, dynamic solution enables continued interactions between clinical trial patients and investigative sites

May 11, 2020

Accelerating COVID-19 and other Vaccine Trials without Sacrificing Data Quality

Learn how a reusable eDiary Platform can benefit sponsors, sites and study participants

April 23, 2020

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

Patients monitor cardiac safety at home with easy-to-use, FDA-cleared KardiaMobile 6L personal ECG

April 20, 2020

ERT Delivers Actionable Insights to Identify COVID-related Clinical Trial Risks

Intuitive COVID-19 Dashboard highlights patient compliance risks to protect study outcomes

April 8, 2020

Cardiac Imaging in Clinical Development: The Benefits of Advanced Imaging Management Systems

Learn the important role cardiac imaging plays in clinical trials and how, when managed expertly and with the benefit of the latest technology and careful oversight, imaging can have broad implications for patient safety as well as trial cost, timing and trial success.

April 1, 2020

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

High-quality clinician-administered data collected during patient home visits advances respiratory trials throughout COVID-19 pandemic

March 30, 2020

ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity

Company’s expertise, infrastructure and flexibility enable remote ECG assessment for fast-tracked COVID-19 vaccines /therapies and other critical pharmaceuticals

March 4, 2020

Estimand Framework: What is it and Why You Need it in Your Clinical Trial

Learn why, if you’re not using estimands in your protocols, you should be! Read this article, which explores the November 2019 ICH E9 guidance addressing statistical methods for use in clinical trials.

February 3, 2020

Assessing Suicide Risk in Clinical Trials: The Patient Knows Best

This article reviews why and when suicidal ideation and behaviors (SIB) should be monitored, compares the different approaches to assessing SIB, and presents information supporting patient self-reported assessments as the preferred approach for detecting and monitoring SIB during clinical trials.

January 9, 2020

ERT Solutions Support 75% of 2019 FDA Approvals

eClinical solutions deliver critical safety, efficacy, and patient experience data to meet sponsors’ drug development goals

December 2, 2019

The Digital Future is Here

This article – including comments by ERT’s Matt McCarty and Dr. Prakriteswar Santikary – reviews the rapidly evolving role of digital healthcare and how companies will need to ensure they are ahead of the curve in order to benefit from the digital health phenomenon.

November 26, 2019

Enhancing Patient Engagement through eClinical Technology

Learn the steps sponsors can take to ensure patient satisfaction during clinical trials and how new technologies can improve and modernize their patient engagement strategies.

November 20, 2019

ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study

Milestone achieved through high precision technology, operational excellence, and continuing innovation.

November 14, 2019

Cardiac Imaging in Oncology Trials: The Benefits of Advanced Imaging Management Systems

During oncologic drug development, clinical trial sponsors often are required to utilize imaging for monitoring cardiotoxicity. For these cardiac safety trials, as in all trials involving imaging, it matters how images are taken, how they are analyzed, and how the process is monitored.

October 17, 2019

Artificial Intelligence Gains Ground Across Healthcare

The potential for Artificial Intelligence (AI) is extensive and its adoption across the healthcare industry is accelerating. But in pharma, legacy systems, insufficient storage capacity, and poor interoperability might hold them back from leveraging its benefits during new product clinical development.

October 15, 2019

Honesty in reporting suicidal ideations and behaviors in Alzheimer’s disease, mild cognitive impairment, and dementias

To ensure patient safety, it’s important to consider the needs, abilities and propensity for honesty in reporting suicidal ideations and behaviors (SIB) among populations with compromised cognitive abilities.

October 9, 2019

Transforming Clinical Development with AI: Applications in Imaging and Performance Risk Management

Here we present how a modern data platform enables the use of AI in clinical development and review particular applications for AI in imaging and in performance/risk management, both of which can speed up clinical trials and reduce overall development costs.

September 27, 2019

ERT Named Health IT Innovator of the Year

Recognized for innovation in accelerating the clinical development of new medical treatments

September 16, 2019

ERT Expands its Commitment to Heart Health and Research

Sponsors Simon’s Heart and lends its cardiac safety technology and expertise to keep children’s hearts safe.

Page 1 of 11
1
2
3
...
11
→

Request A Quote

Request A Quote

NEWS AND MEDIA

FEATURED NEWS/MEDIA

ERT Virtual Visit Capabilities Keep Clinical Trials on Track during COVID-19

Share

Accelerating COVID-19 and other Vaccine Trials without Sacrificing Data Quality

Share

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

Share

All NEWS/MEDIA

FDA Patient-Focused Drug Development Guidance Update: Incorporating Patient Experience Data in Clinical Trials

ERT Virtual Visit Capabilities Keep Clinical Trials on Track during COVID-19

Accelerating COVID-19 and other Vaccine Trials without Sacrificing Data Quality

ERT Offers First Patient-Administered ECG Assessment for Continuation of Clinical Trials during COVID-19

ERT Delivers Actionable Insights to Identify COVID-related Clinical Trial Risks

Cardiac Imaging in Clinical Development: The Benefits of Advanced Imaging Management Systems

ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

ERT’s At-Home Cardiac Safety Assessment Ensures Clinical Trial Continuity

Estimand Framework: What is it and Why You Need it in Your Clinical Trial

Assessing Suicide Risk in Clinical Trials: The Patient Knows Best

ERT Solutions Support 75% of 2019 FDA Approvals

The Digital Future is Here

Enhancing Patient Engagement through eClinical Technology

ERT Cardiac Safety Solution Surpasses 10,000th Clinical Study

Cardiac Imaging in Oncology Trials: The Benefits of Advanced Imaging Management Systems

Artificial Intelligence Gains Ground Across Healthcare

Honesty in reporting suicidal ideations and behaviors in Alzheimer’s disease, mild cognitive impairment, and dementias

Transforming Clinical Development with AI: Applications in Imaging and Performance Risk Management

ERT Named Health IT Innovator of the Year

ERT Expands its Commitment to Heart Health and Research